TCL Archive Research Policy: NIH Trials Don’t Enroll Enough Women to Allow Analysis, GAO Says in Report May 12, 2000
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006